MEN1112/OBT357, a First-in-class Humanized De-Fucosylated Monoclonal Antibody Targeting CD157 Positive Cells in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined